H-Guard Guards Hearts

The UK has made a £500 investment in Invizius' H-Guard—a product that aims to reduce the risk of heart disease by coating dialyzer fibers with an anti-inflamatory “primer” to make them more biocompatible.

Read the full article » | Posted 05-11-2018

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026